WiLAN
TSX : WIN
NASDAQ : WILN

WiLAN

July 20, 2015 10:00 ET

WiLAN Subsidiary Enters into Partnership to License Medical Technologies

OTTAWA, CANADA--(Marketwired - July 20, 2015) - WiLAN (TSX:WIN)(NASDAQ:WILN) today announced that its wholly-owned subsidiary, Surgical Irrigation Technologies Inc., has acquired a portfolio of patented medical technologies relating to surgical ablation and irrigation systems. Surgical ablation technologies help to remove diseased tissue, while irrigation systems help remove debris, clean wounds, and assist with a physician's visual examination. Wound irrigation is considered to be the most consistently effective method of wound cleaning.

"This agreement aligns with WiLAN's efforts to diversify our business and attract quality portfolios through licensing partnerships," said Marc Frechette, Senior Vice-President, WiLAN. "This acquisition is WiLAN's third portfolio in its medical technologies market segment. Since entering this market approximately one year ago, we have already signed four license agreements," added Frechette.

No upfront payment was made to acquire this patent portfolio. Net revenues generated from licensing of the patents under the agreement will be shared between WiLAN and the vendor of the patents. All other terms of the agreement are confidential.

About WiLAN

WiLAN is one of the most successful patent licensing companies in the world and helps companies unlock the value of intellectual property by managing and licensing their patent portfolios. The Company operates in a variety of markets including automotive, digital television, Internet, medical, semiconductor and wireless communication technologies. WiLAN's wholly-owned subsidiary, WiLAN Labs, develops and commercializes innovative solutions to the challenges facing next generation communication networks. Founded in 1992, WiLAN is listed on the TSX and NASDAQ and is included in the S&P/TSX Dividend and Dividend Aristocrats Indexes. For more information: www.wilan.com.

Forward-looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other United States and Canadian securities laws. Forward-looking statements and forward-looking information are based on estimates and assumptions made by WiLAN in light of its experience and its perception of historical trends, current conditions, expected future developments and the expected effects of new business strategies, as well as other factors that WiLAN believes are appropriate in the circumstances. Many factors could cause WiLAN's actual performance or achievements to differ materially from those expressed or implied by the forward-looking statements or forward-looking information. Such factors include, without limitation, the risks described in WiLAN's February 2, 2015 annual information form for the year ended December 31, 2014 (the "AIF"). Copies of the AIF may be obtained at www.sedar.com or www.sec.gov. WiLAN recommends that readers review and consider all of these risk factors and notes that readers should not place undue reliance on any of WiLAN's forward-looking statements. WiLAN has no intention and undertakes no obligation to update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

All trademarks and brands mentioned in this release are the property of their respective owners.

Contact Information

  • Ana Raman
    Director, Investor Relations
    O: 613.688.4333
    C: 613.668.8874
    E: araman@wilan.com